Media Advisory: Yale Brain Cancer Experts Available to Comment on Malignant Gliomas
Yale University brain cancer experts are available to comment on treatments for malignant gliomas, the type of brain cancer Sen. Edward Kennedy has been diagnosed with.
W. Mark Saltzman, the Goizueta Foundation Professor of Chemical and Biomedical Engineering at Yale, is one of the developers of Gliadel, one of the most commonly used chemotherapy agents used to treat gliomas. Giladel is a slow-release chemo-infused wafer that neurosurgeons leave in place on the surface of the brain after surgery.
Office: 203-432-4262 or 203-432-3281
Joachim Baehring, M.D.
Director of the Yale Cancer Center Brain Tumor Center
Assistant professor of neurology and neurosurgery at Yale School of Medicine